Article
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
Pharmacogenetics and genomics - 1 Jul 2017
Megías-Vericat Juan E, Montesinos Pau, Herrero María J, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Poveda José L, Sanz Miguel Á, Aliño Salvador F
Abstract excerpt
Several novel single nucleotide polymorphisms (SNPs) involved in cytarabine cytotoxicity and related to clinical outcomes have been reported recently in a series of 232 pediatric patients with acute myeloid leukemia (AML). We report the first adult AML cohort in which the influence of these SNPs in cytarabine efficacy and toxicity was analyzed. Six of polymorphisms with clinical significance in the previous study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
